FHDC1 Activators
FHDC1 Activators are a class of chemicals that putatively engage with specific cellular and biochemical pathways to enhance the functional activity of FHDC1. These compounds interact with various signaling molecules, enzymes, and receptors to initiate a cascade of events that may lead to the activation of FHDC1. For instance, agents like Phorbol 12-myristate 13-acetate (PMA) could potentiate FHDC1 by activating protein kinase C, which might phosphorylate and thus modulate FHDC1's activity. Forskolin, by increasing intracellular cAMP levels, activates PKC.
Insulin is pivotal in activating the insulin receptor signaling pathway, incorporating the PI3K-Akt pathway. In the event that FHDC1 is an integrant or is modulated by this pathway, the presence of insulin could enhance the activity of FHDC1. Ionomycin, a calcium ionophore, serves to elevate intracellular calcium levels, which in turn can activate calcium-sensitive proteins. If FHDC1 is controlled by calcium-mediated signaling, ionomycin may be capable of boosting its activity.Isoproterenol, a β-adrenergic agonist, stimulates adenylyl cyclase, leading to increased cAMP levels and PKA activation. Should β-adrenergic pathways influence FHDC1, isoproterenol could be effective in magnifying FHDC1's action.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which is involved in numerous signaling pathways. If FHDC1 is regulated by PKC through phosphorylation, PMA could enhance FHDC1 activity by activating PKC. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing cAMP levels, and can activate PKA. If FHDC1 activity is modulated by PKA phosphorylation, forskolin can enhance FHDC1 function indirectly through this pathway. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates the insulin receptor signaling pathway, which includes the PI3K-Akt pathway. If FHDC1 is part of this pathway or regulated by it, insulin can enhance FHDC1 function. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which can activate calcium-dependent proteins. If FHDC1 is regulated by calcium signaling, ionomycin could enhance its activity. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a β-adrenergic agonist that activates adenylyl cyclase, raising cAMP levels and activating PKA. If FHDC1 is influenced by β-adrenergic signaling, isoproterenol can enhance its activity. | ||||||
(±)-S-Nitroso-N-acetylpenicillamine | 79032-48-7 | sc-200319B sc-200319 sc-200319A | 10 mg 20 mg 100 mg | $74.00 $114.00 $374.00 | 18 | |
Nitric oxide donors release NO, which can activate guanylyl cyclase and increase cGMP levels. If FHDC1 is modulated by cGMP-dependent protein kinases, this could enhance FHDC1 activity. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits GSK-3, a negative regulator of the Wnt signaling pathway. If FHDC1 is regulated by Wnt signaling components, lithium chloride can enhance FHDC1 indirectly. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid regulates gene expression through retinoic acid receptors. If FHDC1 is regulated at a transcriptional level by retinoic acid, its functional activity could be enhanced. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
Estrogen binds to estrogen receptors and can modulate gene expression. If FHDC1 is estrogen-responsive, estrogen can enhance its activity. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl cAMP is a membrane-permeable analogue of cAMP that activates PKA. If FHDC1 is modulated by PKA, this compound can enhance its activity. | ||||||